These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18192679)

  • 1. Huntingtin-associated protein-1 is a modifier of the age-at-onset of Huntington's disease.
    Metzger S; Rong J; Nguyen HP; Cape A; Tomiuk J; Soehn AS; Propping P; Freudenberg-Hua Y; Freudenberg J; Tong L; Li SH; Li XJ; Riess O
    Hum Mol Genet; 2008 Apr; 17(8):1137-46. PubMed ID: 18192679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age at onset in Huntington's disease: replication study on the association of HAP1.
    Karadima G; Dimovasili C; Koutsis G; Vassilopoulos D; Panas M
    Parkinsonism Relat Disord; 2012 Nov; 18(9):1027-8. PubMed ID: 22698993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The S18Y polymorphism in the UCHL1 gene is a genetic modifier in Huntington's disease.
    Metzger S; Bauer P; Tomiuk J; Laccone F; Didonato S; Gellera C; Soliveri P; Lange HW; Weirich-Schwaiger H; Wenning GK; Melegh B; Havasi V; Balikó L; Wieczorek S; Arning L; Zaremba J; Sulek A; Hoffman-Zacharska D; Basak AN; Ersoy N; Zidovska J; Kebrdlova V; Pandolfo M; Ribaï P; Kadasi L; Kvasnicova M; Weber BH; Kreuz F; Dose M; Stuhrmann M; Riess O
    Neurogenetics; 2006 Mar; 7(1):27-30. PubMed ID: 16369839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age at onset in Huntington's disease is modified by the autophagy pathway: implication of the V471A polymorphism in Atg7.
    Metzger S; Saukko M; Van Che H; Tong L; Puder Y; Riess O; Nguyen HP
    Hum Genet; 2010 Oct; 128(4):453-9. PubMed ID: 20697744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Study of Triplet-Primed PCR for Identification of CAG Repeat Expansion in the HTT Gene in a Cohort of 503 Indian Cases with Huntington's Disease Symptoms.
    Chheda P; Chanekar M; Salunkhe Y; Dama T; Pais A; Pande S; Bendre R; Shah N
    Mol Diagn Ther; 2018 Jun; 22(3):353-359. PubMed ID: 29619771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Steady-State Mutant Huntingtin mRNA in Huntington's Disease Brain.
    Liu W; Chaurette J; Pfister EL; Kennington LA; Chase KO; Bullock J; Vonsattel JP; Faull RL; Macdonald D; DiFiglia M; Zamore PD; Aronin N
    J Huntingtons Dis; 2013; 2(4):491-500. PubMed ID: 25062733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parent-of-origin differences of mutant HTT CAG repeat instability in Huntington's disease.
    Aziz NA; van Belzen MJ; Coops ID; Belfroid RD; Roos RA
    Eur J Med Genet; 2011; 54(4):e413-8. PubMed ID: 21540131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic analysis of candidate genes modifying the age-at-onset in Huntington's disease.
    Metzger S; Bauer P; Tomiuk J; Laccone F; Didonato S; Gellera C; Mariotti C; Lange HW; Weirich-Schwaiger H; Wenning GK; Seppi K; Melegh B; Havasi V; Balikó L; Wieczorek S; Zaremba J; Hoffman-Zacharska D; Sulek A; Basak AN; Soydan E; Zidovska J; Kebrdlova V; Pandolfo M; Ribaï P; Kadasi L; Kvasnicova M; Weber BH; Kreuz F; Dose M; Stuhrmann M; Riess O
    Hum Genet; 2006 Sep; 120(2):285-92. PubMed ID: 16847693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FAN1 modifies Huntington's disease progression by stabilizing the expanded HTT CAG repeat.
    Goold R; Flower M; Moss DH; Medway C; Wood-Kaczmar A; Andre R; Farshim P; Bates GP; Holmans P; Jones L; Tabrizi SJ
    Hum Mol Genet; 2019 Feb; 28(4):650-661. PubMed ID: 30358836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dominant effects of the Huntington's disease HTT CAG repeat length are captured in gene-expression data sets by a continuous analysis mathematical modeling strategy.
    Lee JM; Galkina EI; Levantovsky RM; Fossale E; Anne Anderson M; Gillis T; Srinidhi Mysore J; Coser KR; Shioda T; Zhang B; Furia MD; Derry J; Kohane IS; Seong IS; Wheeler VC; Gusella JF; MacDonald ME
    Hum Mol Genet; 2013 Aug; 22(16):3227-38. PubMed ID: 23595883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype.
    Wegrzynowicz M; Bichell TJ; Soares BD; Loth MK; McGlothan JS; Mori S; Alikhan FS; Hua K; Coughlin JM; Holt HK; Jetter CS; Pomper MG; Osmand AP; Guilarte TR; Bowman AB
    J Huntingtons Dis; 2015; 4(1):17-36. PubMed ID: 26333255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of the Influence of TBP CAG/CAA Repeats in Conjunction with HTT CAG Repeats on Huntington's Disease Age at Onset in a Brazilian Sample.
    da Silva IDS; Apolinário TA; de Andrade Agostinho L; Paiva CLA
    J Mol Neurosci; 2022 May; 72(5):1116-1124. PubMed ID: 35275350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is There Convincing Evidence that Intermediate Repeats in the HTT Gene Cause Huntington's Disease?
    Oosterloo M; Van Belzen MJ; Bijlsma EK; Roos RA
    J Huntingtons Dis; 2015; 4(2):141-8. PubMed ID: 26397895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The p. R151C Polymorphism in MC1R Gene Modifies the Age of Onset in Spanish Huntington's Disease Patients.
    Tell-Marti G; Puig-Butille JA; Gimenez-Xavier P; Segu-Roig A; Potrony M; Badenas C; Alvarez V; Millán JM; Trujillo-Tiebas MJ; Ramos-Arroyo MA; Milà M; Puig S
    Mol Neurobiol; 2017 Jul; 54(5):3906-3910. PubMed ID: 27924526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple clinical features of Huntington's disease correlate with mutant HTT gene CAG repeat lengths and neurodegeneration.
    Podvin S; Reardon HT; Yin K; Mosier C; Hook V
    J Neurol; 2019 Mar; 266(3):551-564. PubMed ID: 29956026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The number of CAG repeats within the normal allele does not influence the age of onset in Huntington's disease.
    Klempíř J; Zidovská J; Stochl J; Ing VK; Uhrová T; Roth J
    Mov Disord; 2011 Jan; 26(1):125-9. PubMed ID: 21322024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of age at onset of Huntington disease patients by variations in TP53 and human caspase activated DNase (hCAD) genes.
    Chattopadhyay B; Baksi K; Mukhopadhyay S; Bhattacharyya NP
    Neurosci Lett; 2005 Feb; 374(2):81-6. PubMed ID: 15644269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interrupting sequence variants and age of onset in Huntington's disease: clinical implications and emerging therapies.
    Wright GEB; Black HF; Collins JA; Gall-Duncan T; Caron NS; Pearson CE; Hayden MR
    Lancet Neurol; 2020 Nov; 19(11):930-939. PubMed ID: 33098802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of triplet repeats in the huntingtin gene in Japanese families affected with Huntington's disease.
    Masuda N; Goto J; Murayama N; Watanabe M; Kondo I; Kanazawa I
    J Med Genet; 1995 Sep; 32(9):701-5. PubMed ID: 8544189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism.
    Seong IS; Ivanova E; Lee JM; Choo YS; Fossale E; Anderson M; Gusella JF; Laramie JM; Myers RH; Lesort M; MacDonald ME
    Hum Mol Genet; 2005 Oct; 14(19):2871-80. PubMed ID: 16115812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.